Elisa Oyj (FRA:EIA)

Intra-Cellular Therapies Revenue

Elisa Oyj had revenue of 552.40M EUR in the quarter ending June 30, 2025, with 2.03% growth. This brings the company's revenue in the last twelve months to 2.22B, up 1.82% year-over-year. In the year 2024, Elisa Oyj had annual revenue of 2.19B with 0.50% growth.

• Revenue (ttm): 2.22B
• Revenue Growth: +1.82%
• P/S Ratio: 3.27
• Revenue / Employee: 355.35K
• Employees: 6,731
• Market Cap: 7.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.19B	11.00M	0.50%
Dec 31, 2023	2.18B	51.00M	2.39%
Dec 31, 2022	2.13B	131.60M	6.59%
Dec 31, 2021	2.00B	103.30M	5.45%
Dec 31, 2020	1.89B	51.10M	2.77%